---
figid: PMC5602294__kccy-16-18-1360633-g001
figtitle: Biosynthetic pathway of NAD+ production starting from Na
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC5602294
filename: kccy-16-18-1360633-g001.jpg
figlink: /pmc/articles/PMC5602294/figure/f0001/
number: F1
caption: 'Biosynthetic pathway of NAD+ production starting from Na. Nicotinic acid
  (Na) is converted to NAD+ through the 3-step Preiss-Handler pathway. NAPRT catalyzes
  the formation of nicotinic acid mononucleotide (NaMN) by adding a 5-phosphoribose
  group (P-ribose) from 5-phosphoribosyl-1-pyrophosphate to Na. NaMN is converted
  to nicotinic acid adenine dinucleotide (NaAD+) by nicotinamide mononucleotide adenylyltransferase
  1/3 (NMNAT1–3). Finally, NAD+ synthase 1 (NADSYN1) converts NaAD+ to NAD+. The NAPRT
  gene is amplified and overexpressed in a subset of tumors, including ovarian, breast,
  pancreatic and prostate cancer. NAPRT-derived NAD+ supports the activity of DNA
  repair enzymes, such as PARP1/2, which, in turn, may be especially important in
  cancer cells with defective homologous recombination DNA repair to avoid catastrophic
  DNA damage. In addition, NAPRT-mediated NAD+ production turns out to be especially
  important for replenishing the mitochondrial NAD+ stores, for promoting OXPHOS,
  ATP synthesis, and protein synthesis and, ultimately, for regulating cell size.
  PAR: poly (ADP-ribose).'
papertitle: 'Nicotinic acid: A case for a vitamin that moonlights for cancer?.'
reftext: Francesco Piacente, et al. Cell Cycle. 2017;16(18):1635-1636.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9510155
figid_alias: PMC5602294__F1
figtype: Figure
redirect_from: /figures/PMC5602294__F1
ndex: 6ccb0dc7-def2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5602294__kccy-16-18-1360633-g001.html
  '@type': Dataset
  description: 'Biosynthetic pathway of NAD+ production starting from Na. Nicotinic
    acid (Na) is converted to NAD+ through the 3-step Preiss-Handler pathway. NAPRT
    catalyzes the formation of nicotinic acid mononucleotide (NaMN) by adding a 5-phosphoribose
    group (P-ribose) from 5-phosphoribosyl-1-pyrophosphate to Na. NaMN is converted
    to nicotinic acid adenine dinucleotide (NaAD+) by nicotinamide mononucleotide
    adenylyltransferase 1/3 (NMNAT1–3). Finally, NAD+ synthase 1 (NADSYN1) converts
    NaAD+ to NAD+. The NAPRT gene is amplified and overexpressed in a subset of tumors,
    including ovarian, breast, pancreatic and prostate cancer. NAPRT-derived NAD+
    supports the activity of DNA repair enzymes, such as PARP1/2, which, in turn,
    may be especially important in cancer cells with defective homologous recombination
    DNA repair to avoid catastrophic DNA damage. In addition, NAPRT-mediated NAD+
    production turns out to be especially important for replenishing the mitochondrial
    NAD+ stores, for promoting OXPHOS, ATP synthesis, and protein synthesis and, ultimately,
    for regulating cell size. PAR: poly (ADP-ribose).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NAPRT
  - NMNAT1
  - NMNAT3
  - NADSYN1
  - NR1I2
  - JTB
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - ATP8A2
  - na
  - Naprt
  - Nmnat
  - par
  - para
  - par-6
  - Parp
  - ATPsynbeta
  - Atpalpha
  - naprt
  - nmnat1
  - nmnat3
  - nadsyn1
  - parp14rs2.1
  - ADP-ribose
  - P-ribose
---
